Study of Olaparib and Temozolomide in Patients With Recurrent Small Cell Lung Cancer Following Failure of Prior Chemotherapy

NCT02446704 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: Olaparib
DRUG: Temozolomide

Sponsor

Zofia Piotrowska

Collaborators

[object Object]